CAS NO.:4764-17-4 3,4-Methylenedioxyamphetamine ;MDA C10H13NO2 Recreational Club Clinical Composite Psychoactive Aphrodisiac Designer Drug

3,4-Methylenedioxyamphetamine (MDA), is an empathogen-entactogen, psychostimulant, and psychedelic drug of the amphetamine family that is encountered mainly as a recreational drug.



Detail:


        3,4-Methylenedioxyamphetamine (MDA), is an empathogen-entactogen, psychostimulant, and psychedelic drug of the amphetamine family that is encountered mainly as a recreational drug. In terms of pharmacology, MDA acts most importantly as a serotonin-norepinephrine-dopamine releasing agent (SNDRA). Due to its euphoriant and hallucinogenic effects, the drug is a controlled substance and its possession and sale are illegal in most countries.

        MDA is rarely sought after as a recreational drug compared to other drugs in the amphetamine family, however it remains an important and widely used drug due to it being a primary metabolite, the product of hepatic N-dealkylation, of MDMA (ecstasy), In addition, it's not uncommon to find MDA as an adulterant of illicitly produced MDMA.


Recreational:

        Although illegal, MDA is bought, sold, and used as a recreational 'love drug', due to its enhancement of mood and empathy. A recreational dose of MDA is sometimes cited as being between 100 and 160 mg.

Adverse effects:

        MDA produces serotonergic neurotoxic effects, thought to be activated by initial metabolism of MDA. In addition, MDA activates a response of the neuroglia, though this subsides after use.

Overdose:

        Symptoms of acute toxicity may include agitation, sweating, increased blood pressure and heart rate, dramatic increase in body temperature, convulsions, and death. Death is usually caused by cardiac effects and subsequent hemorrhaging in the brain (stroke).



Pharmacodynamics:

        MDA is a substrate of the serotonin, norepinephrine, dopamine, and vesicular monoamine transporters, as well as a TAAR1 agonist, and for these reasons acts as a reuptake inhibitor and releasing agent of serotonin, norepinephrine, and dopamine (that is, it is an SNDRA). It is also an agonist of the serotonin 5-HT2A, 5-HT2B, and 5-HT2C receptors and shows affinity for the α2A-, α2B-, and α2C-adrenergic receptors and serotonin 5-HT1A and 5-HT7 receptors.

The (S)-optical isomer of MDA is more potent than the (R)-optical isomer as a psychostimulant, possessing greater affinity for the three monoamine transporters.

        In terms of the subjective and behavioral effects of MDA, it is thought that serotonin release is required for its empathogen-entactogen effects, release of dopamine and norepinephrine is responsible for its psychostimulant effects, dopamine release is necessary for its euphoriant (rewarding and addictive) effects, and direct agonism of the serotonin 5-HT2A receptor is causative of its psychedelic effects.

Comparison with MDMA

        The effect on serotonin may explain the similar entactogenic effects of MDMA and MDA. However, (S)-MDA has higher potency as an agonist of the 5-HT2A receptor than (R)-MDMA; thus MDA tends to cause more psychedelic-like effects, such as visual hallucinations. MDMA can also produce psychedelic-like visual effects, though these are generally less pronounced than those of MDA or require higher doses to become apparent. Relative to MDMA, MDA is also a more potent releasing agent of norepinephrine and dopamine and hence is more stimulating in comparison. In addition, MDMA is slighty less neurotoxic to serotonergic neurons than MDA at the same dose. This is in contrast to Methamphetamine and Amphetamine, where the latter is not neurotoxic but the former methylated form is.

Pharmacokinetics:

        The duration of the drug has been reported as about 6 to 8 hours.

Chemistry:

        MDA is a substituted methylenedioxylated phenethylamine and amphetamine derivative. In relation to other phenethylamines and amphetamines, it is the 3,4-methylenedioxy, α-methyl derivative of β-phenylethylamine, the 3,4-methylenedioxy derivative of amphetamine, and the N-demethyl derivative of MDMA.


Packing

Packing 1-4

Shipping

Shipping 1-4

Payment

Bitcoin;WU;MG;Bank

Purity

Pure

Appearance:

Conform

Date of delivery:

Within 48 hours when you finished the payment

Sales territory:

All over the world

Stock:

Enough

Transportation insurance:

Yes

Shipping origin:

HongKong

Synthesis of cycle:

2-7 days

Application range

Recreational Club Drugs;Chemistry ExperimentReagent and Other

Manufacturer:

Universal drugs Lab

Expiration date

5 Years


        We can provide Hallucinogens;Serotonin receptor modulators;Ergolines;Amphetamine;Anorectics;Decongestants;Monoamine releasing agents;Phenethylamines;Anxiolytics;Benzodiazepines;GABAA receptor positive modulators;Recreational drug;Clubdrug;Euphoriants;Opioid receptor modulators;Analgesics;Stimulants;Monoamine neurotoxins;Serotonin receptor modulators;Sigma receptor modulators;Anticonvulsants;Antidotes;Glycine receptor modulators;Toxins;Globular proteins;chemical warfare and other chemical reagent .

       You can send message to us if you not see what you want product in our Web ,we will provide synthetic services for you.The synthesis time usually need 1-5 days.Wishing you a happy shopping.

Warm prompt:Please use it for chemical experiment,We are not liable for any legal liability.





Product Tags clinical drugs          cas 124 17 4          ibm 4764          mdas          cas drugs          drugs ca          c10h13no2 phenibut          c10h13no2 nmr          gracemor recreation club         

INQUIRY

Contact us for all information about the product


click here to leave a message

leave a message
If you are interested in our products and want to know more details,please leave a message here,we will reply you as soon as we can.